Daniel J Cameron

Summary

Publications

  1. ncbi Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial
    D Cameron
    Northern Westchester Hospital, Mount Kisco, NY, USA
    Minerva Med 99:489-96. 2008
  2. ncbi Clinical trials validate the severity of persistent Lyme disease symptoms
    Daniel J Cameron
    First Medical Associates, Mt Kisco, New York 10549, USA
    Med Hypotheses 72:153-6. 2009
  3. ncbi Insufficient evidence to deny antibiotic treatment to chronic Lyme disease patients
    Daniel J Cameron
    First Medical Associates, Medicine, 175 Main Street, Mount Kisco, NY 10549, USA
    Med Hypotheses 72:688-91. 2009

Detail Information

Publications3

  1. ncbi Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial
    D Cameron
    Northern Westchester Hospital, Mount Kisco, NY, USA
    Minerva Med 99:489-96. 2008
    ..A significant gain in the QOL for subjects randomized to amoxicillin in this RCT without serious adverse events is consistent with the goal of improving patient's QOL and consequently worthy of further study...
  2. ncbi Clinical trials validate the severity of persistent Lyme disease symptoms
    Daniel J Cameron
    First Medical Associates, Mt Kisco, New York 10549, USA
    Med Hypotheses 72:153-6. 2009
    ..quot;..
  3. ncbi Insufficient evidence to deny antibiotic treatment to chronic Lyme disease patients
    Daniel J Cameron
    First Medical Associates, Medicine, 175 Main Street, Mount Kisco, NY 10549, USA
    Med Hypotheses 72:688-91. 2009
    ....